Zimmer Biomet Holdings, Inc.’s Registered Notes Offering

Cravath represented the underwriters in connection with the €700 million registered notes offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The transaction closed on November 20, 2024.

The Cravath team included partner Ryan J. Patrone and associates Nicolas Thomson and Helen Catherine Darby on capital markets matters; partner Arvind Ravichandran and associate Eduardo D. Jacobo on tax matters; and partner Matthew Morreale on environmental matters. Sasha G. Savitsky also worked on capital markets matters.